Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

25
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
25
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

19
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

23
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
23
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

482
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
482
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

40
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary epidemiological and clinical profile of the 2024 pediatric pertussis outbreak: a retrospective analysis.

Frontiers in pediatrics·2026
Same author

Impact of enhanced recovery after surgery (ERAS) protocols on clinical outcomes of patients undergoing anterior cervical discectomy and fusion: A retrospective study.

Medicine·2026
Same author

Correction: Zinc oxide nanoparticle chelated phosphocreatine-grafted chitosan composite hydrogels for enhancing osteogenesis and angiogenesis in bone regeneration.

Frontiers in medicine·2026
Same author

VEGF-C maturation mediated by CircFOCAD-orchestrated CCBE1 and ADAM10 expression in nuclear-cytoplasmic synergy drives lymphatic metastasis.

Oncogene·2026
Same author

Genome-wide identification and expression analysis of the SHAGGY-like kinase gene family in foxtail millet (<i>Setaria italica</i> L.).

Frontiers in plant science·2026
Same author

Effect of preoperative biliary drainage on peripheral circulating tumor cells after pancreaticoduodenectomy in patients with resectable periampullary carcinoma and obstructive jaundice.

Translational gastroenterology and hepatology·2026

Related Experiment Video

Updated: Aug 16, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

Machine learning models in heart failure with mildly reduced ejection fraction patients.

Hengli Zhao1,2,3,4, Peixin Li1,2,3, Guoheng Zhong1,2,3

  • 1State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Frontiers in Cardiovascular Medicine
|December 19, 2022
PubMed
Summary

Machine learning models effectively predict mortality and re-hospitalization in heart failure with mildly reduced ejection fraction (HFmrEF) patients. The Kansas City Cardiomyopathy Questionnaire (KCCQ) score is a key predictor for HFmrEF readmissions.

Keywords:
LASSO Cox regression analysisheart failureheart failure with mildly reduced ejection fractionmachine learning (ML)random forest (RF)

More Related Videos

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.6K

Related Experiment Videos

Last Updated: Aug 16, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.6K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Biostatistics

Background:

  • Heart failure with mildly reduced ejection fraction (HFmrEF) is a distinct clinical phenotype.
  • Current guidelines lack robust risk stratification models for HFmrEF mortality and re-hospitalization.
  • Accurate prediction is crucial for managing HFmrEF patients and improving outcomes.

Purpose of the Study:

  • To develop and validate a novel machine learning (ML) model for predicting mortality and HF re-hospitalization in HFmrEF patients.
  • To compare the performance of ML models against traditional risk stratification methods.
  • To identify key predictors for HFmrEF patient outcomes.

Main Methods:

  • Utilized data from the TOPCAT trial for HFmrEF patients (ejection fraction 45-49%).
  • Constructed eight ML models using 72 candidate variables.
  • Assessed model discrimination using Harrell concordance index (C-index) and DeLong test; evaluated calibration via bias-corrected estimates.

Main Results:

  • LASSO Cox regression demonstrated superior performance for 1- and 6-year mortality prediction (C-indices up to 0.83).
  • Random forest (RF) model showed best discrimination for HF re-hospitalization (C-indices up to 0.85).
  • Kansas City Cardiomyopathy Questionnaire (KCCQ) subscale scores emerged as the most significant predictor for HFmrEF re-hospitalization.

Conclusions:

  • ML-based models significantly outperform traditional approaches in predicting mortality and re-hospitalization for HFmrEF.
  • The KCCQ score is a critical factor requiring increased attention in the clinical management of HFmrEF.
  • Validated ML models offer a promising tool for personalized risk assessment in HFmrEF.